Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
ARK Genomic Revolution ETF: Value Realization Will Take Time
04:46am, Monday, 03'rd May 2021
ARK Genomic Revolution ETF: Value Realization Will Take Time
Why Pacific Biosciences of California Stock Is Down Today
12:59pm, Friday, 30'th Apr 2021
The company released its first-quarter earnings report, but that doesn't tell the whole story.
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q1 2021 Results - Earnings Call Transcript
12:22am, Friday, 30'th Apr 2021
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q1 2021 Results - Earnings Call Transcript
Pacific Biosciences: Q1 Earnings Insights
05:25pm, Thursday, 29'th Apr 2021
Shares of Pacific Biosciences (NASDAQ:PACB) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 4600.00% over the past year to ($0.45), which
Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results
04:05pm, Thursday, 29'th Apr 2021
MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:05pm, Thursday, 22'nd Apr 2021
MENLO PARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality seque
Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call
04:05pm, Thursday, 15'th Apr 2021
MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its first quarter 2021 financial result
We're really excited that these genomics companies, says Ark's Simon Barnett
07:02pm, Monday, 12'th Apr 2021
Simon Barnett, ARK Invest's genomics analyst, discusses the company's belief in Invitae, its other top picks and why ARK invests the way it does.
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
07:27am, Friday, 02'nd Apr 2021
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:30pm, Tuesday, 02'nd Mar 2021
MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality seque
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
04:04pm, Friday, 26'th Feb 2021
MENLO PARK, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences:
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
07:00am, Friday, 26'th Feb 2021
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.
Pacific Biosciences' (PACB) Sequel II Gets Deployed by LabCorp
09:52am, Tuesday, 23'rd Feb 2021
Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 variants in the United States.
ARKG: Precautionary Measures, But Transformational Objectives Remain Intact
09:23am, Monday, 22'nd Feb 2021
Cathie Wood and her team have shown investors that they have the capability to turn double-digit growth dreams into reality.
Pacific Biosciences Stock May Continue To Rally After 27% Gains In Last 10 Days
06:30am, Friday, 19'th Feb 2021
The stock price of Pacific Biosciences of California a biotechnology company that develops gene sequencing systems, has seen a solid 27% rise over the last ten trading days, though it's down 4% over t
